Artritis reumatoide

  1. Turrión Nieves, A.
  2. Martín Holguera, R.
  3. Pérez Gómez, A.
  4. Álvarez de Mon-Soto, M.
Journal:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Year of publication: 2017

Issue Title: Enfermedades del sistema inmune y reumatológicas (V) Artritis reumatoide, síndrome de Sjögren y uveítis

Series: 12

Issue: 28

Pages: 1615-1625

Type: Article

DOI: 10.1016/J.MED.2017.02.010 DIALNET GOOGLE SCHOLAR

More publications in: Medicine: Programa de Formación Médica Continuada Acreditado

Abstract

Concept Rheumatoid arthritis is a systemic inflammatory disease of immune etiopathogenesis. Epidemiology Presence of persistent synovitis in the joints. The pattern of joint involvement is usually symmetrical and erosive and can develop at any age. Etiopathogenesis It is unknown, repeated exposure to certain environmental agents (tobacco and citrullination) has been related as a possible harmful mechanism, associated to a genetic predisposition to an immune response. Clinical manifestations Patients present swelling of the joints, and polyarticular clinical forms usually appear, with multiple clinical involvement and progress patterns. Other extra-articular manifestations can develop, such as skin diseases, rheumatoid nodules, or pleuropulmonary or hematological manifestations. Diagnosis It is conducted upon the presence of arthritis in association with radiographic and analytical data such as a positive rheumatoid factor and/or anti-citrullinated peptide antibodies. Treatment The course of the disease is poor if left untreated. Early treatment prevents structural progression. Some patients respond to traditional therapies with DMARDs (mostly methotrexate) and avoid further damage, but in many cases biological drugs are required, such as anti-TNF/anti-interleukin, or even anti-CD20, that have played an undisputed role in this disease.

Bibliographic References

  • Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet. 2001;358 (9285): 903-11.
  • Schur PH, Moreland LW. General principles of management of rheumatoid arthritis. 2012.
  • Bawadekar M, Gendron Fitzpatrick A, Rebernick R, Shim D, Warner TF, Nicholas AP. Tumor necrosis factor alpha, citrullination, and peptidylarginine deiminase 4 in lung and joint inflammation. Arthritis Res Ther. 2016;18(1):173-016-1068-0.
  • Chang X, Yamada R, Suzuki A, Sawada T, Yoshino S, Tokuhiro S. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis. Rheumatology (Oxford). 2005;44(1):40-50.
  • Moura RA, Cascao R, Perpetuo I, Canhao H, Vieira-Sousa E, Mourao AF. Cytokine pattern in very early rheumatoid arthritis favours B-cell activation and survival. Rheumatology (Oxford). 2011;50(2):278-82.
  • Van der Heijde DM, van Leeuwen MA, van Riel PL, Koster AM, van ‘t Hof MA, Van Rijswijk MH. Biannual radiographic assessments of hands and feet in a three year prospective followup of patients with early rheumatoid arthritis. Arthritis Rheum. 1992;35(1):26-34.
  • Devauchelle-Pensec V, Saraux A, Alapetite S, Colin D, Le Goff P. Diagnostic value of radiographs of the hands and feet in early rheumatoid arthritis. Joint Bone Spine 2002;69(5):434-41.
  • Sociedad Española de Reumatología. Guía de práctica clínica para el manejo de la Artritis Reumatoide 2007. Actualizado en 2011.
  • Lovy MR, Starkebaum G, Uberoi S. Hepatitis C infection presenting with rheumatic manifestations: a mimic of rheumatoid arthritis. J Rheu-matol. 1996;23(6):979-83.
  • Goodisson LA, Bourne JT, Maharajan S. A case of bilateral peripheral ulcerative keratitis following treatment with rituximab. Rheumatology (Oxford). 2010;49(3):609-10.
  • Barrett EM, Scott DG, Wiles NJ, Symmons DP. The impact of rheumatoid arthritis on employment status in the early years of disease: a UK community based study. Rheumatology (Oxford). 2000;39(12):1403-9.
  • Sattar N, McCarey DW, Capell H, McInnes IB. Explaining how “high grade” systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation. 2003;108(24):2957-63.
  • Callahan LF, Pincus T. Mortality in the rheumatic diseases. Arthritis Care Res. 1995;8(4):229-41.
  • Sokolove J, Strand V. Rheumatoid arthritis classification criteria It’s finally time to move on! Bull NYU Hosp Jt Dis. 2010;68(3):232-8.
  • Scott DL. Prognostic factors in early rheumatoid arthritis. Rheumatology (Oxford). 2000;39Suppl1:24-9.
  • Zendman AJ, van Venrooij WJ, Pruijn GJ. Use and significance of anti-CCP autoantibodies in rheumatoid arthritis. Rheumatology (Oxford). 2006;45(1):20-5.
  • Ejbjerg BJ, Narvestad E, Jacobsen S, Thomsen HS, Ostergaard M. Optimised, low cost, low field dedicated extremity MRI is highly specific and sensitive for synovitis and bone erosions in rheumatoid arthritis wrist and finger joints: comparison with conventional high field MRI and radiography. Ann Rheum Dis. 2005;64(9):1280-7.
  • Masuko-Hongo K, Kato T, Nishioka K. Virus associated arthritis. Best Pract Res Clin Rheumatol. 2003;17(2):309-18.
  • Miner JJ, Aw Yeang HX, Fox JM, Taffner S, Malkova ON, Oh ST. Chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritis. Arthritis Rheumatol. 2015;67(5):1214-20.
Data source: Dialnet